Surgeon and medical oncologist peer network effects on the uptake of the 21‐gene breast cancer recurrence score assay

Surgeon and medical oncologist peer network effects on the uptake of the 21‐gene breast cancer recurrence score assay

Abstract Background Drivers behind the adoption of gene expression profiling in breast cancer oncology have been shown to include exposure to physician colleagues’ use of a given genomic test. We examined adoption of the Oncotype DX 21‐gene breast cancer recurrence score assay (ODX) in the United St...

Full description

Bibliographic Details
Main Authors: Ronnie Zipkin, Andrew Schaefer, Mary Chamberlin, Tracy Onega, Alistair J. O'Malley, Erika L. Moen
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Cancer Medicine
Subjects:
breast cancer
genetic testing
medicare
oncologists
surgeons
Online Access:https://doi.org/10.1002/cam4.3720

Internet

https://doi.org/10.1002/cam4.3720

Similar Items